Hextar Healthcare Berhad Förvaltning

Förvaltning kriterier kontrolleras 1/4

Vi har för närvarande inte tillräcklig information om VD:n.

Viktig information

Chin Khoo

Verkställande direktör

n/a

Total ersättning

VD-lön i procent	n/a
Anställning som VD	11.7yrs
Ägande av VD	0.006%
Ledningens genomsnittliga anställningstid	inga uppgifter
Styrelsens genomsnittliga mandatperiod	2.9yrs

Senaste uppdateringar av ledningen

Recent updates

Unpleasant Surprises Could Be In Store For Hextar Healthcare Berhad's (KLSE:HEXCARE) Shares

Nov 06

Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking

Dec 18

The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing

Aug 30

We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger

May 27

Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)

Feb 26

Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?

Nov 17

If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late

May 11

What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?

Apr 12

Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 02

Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today

Feb 09

Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive

Jan 22

How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?

Jan 04

If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today

Dec 17

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?

Dec 02

Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?

Nov 18

What Does Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) CEO Pay Reveal?

Jul 14

Analys av ersättningar till VD

Hur har Chin Khoo:s ersättning förändrats jämfört med Hextar Healthcare Berhad:s resultat?
Datum	Total ersättning	Lön	Företagets resultat
Dec 31 2024	n/a	n/a	-RM 14m
Sep 30 2024	n/a	n/a	-RM 52m
Jun 30 2024	n/a	n/a	-RM 58m
Mar 31 2024	n/a	n/a	-RM 61m
Dec 31 2023	n/a	n/a	-RM 64m
Sep 30 2023	n/a	n/a	-RM 74m
Jun 30 2023	n/a	n/a	-RM 69m
Mar 31 2023	n/a	n/a	-RM 61m
Dec 31 2022	n/a	n/a	-RM 56m
Sep 30 2022	n/a	n/a	RM 10m
Jun 30 2022	n/a	n/a	RM 39m
Mar 31 2022	n/a	n/a	RM 102m
Dec 31 2021	RM 1m	RM 1m	RM 186m
Sep 30 2021	n/a	n/a	RM 236m
Jun 30 2021	n/a	n/a	RM 250m
Mar 31 2021	n/a	n/a	RM 208m
Dec 31 2020	RM 1m	RM 1m	RM 131m
Sep 30 2020	n/a	n/a	RM 76m
Jun 30 2020	n/a	n/a	RM 39m
Mar 31 2020	n/a	n/a	RM 19m
Dec 31 2019	RM 943k	RM 943k	RM 11m
Sep 30 2019	n/a	n/a	RM 11m
Jun 30 2019	n/a	n/a	RM 10m
Mar 31 2019	n/a	n/a	RM 10m
Dec 31 2018	RM 613k	RM 613k	RM 9m

Ersättning vs marknad: Otillräckliga data för att fastställa om Chin s total kompensation är rimlig jämfört med företag av liknande storlek på MY marknaden.

Ersättning vs inkomst: Ersättningen från Chin har varit i linje med företagets resultat under det senaste året.

VD OCH KONCERNCHEF

Chin Khoo (65 yo)

11.7yrs

Anställning

Mr. Chin Leng Khoo has been Group Managing Director and Director of Hextar Healthcare Berhad (formerly known as Rubberex Corporation (M) Berhad) since July 1, 2013 and served as its Financial Manager. Mr....

Styrelseledamöter

Namn	Position	Anställning	Kompensation	Ägarskap
Chin Khoo	Group MD & Director	11.7yrs	inga uppgifter	0.0059% MYR 9.4k
Hsu-Ming Goh	Non-Independent Executive Director	3.6yrs	inga uppgifter	inga uppgifter
Yee Fuan Sim	Independent Non-Executive Director	1.8yrs	RM 34.00k	inga uppgifter
Jee Min Liew	Independent & Non Executive Chairman	3.6yrs	RM 66.00k	inga uppgifter
Siew Lim	Independent Non-Executive Director	2.2yrs	RM 55.00k	inga uppgifter
Chin Cheng	Independent Non-Executive Director	2.2yrs	RM 57.00k	inga uppgifter

2.9yrs

Genomsnittlig anställningstid

65yo

Genomsnittlig ålder

Erfaren styrelse: HEXCARE s styrelse anses inte vara erfaren ( 2.9 års genomsnittlig mandatperiod), vilket föreslår en ny styrelse.

Företagsanalys och finansiella data Status

Uppgifter	Senast uppdaterad (UTC-tid)
Analys av företag	2025/03/12 14:09
Aktiekurs vid dagens slut	2025/03/12 00:00
Intäkter	2024/12/31
Årlig intjäning	2024/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

Paket	Uppgifter	Tidsram	Exempel US-källa
Företagets finansiella ställning	10 år	Resultaträkning Kassaflödesanalys Balansräkning	SEC Form 10-K SEC Form 10-Q
Analytikernas konsensusuppskattningar	+3 år	Prognos för finansiella poster Analytikernas prismål	Rapporter från analytiker Blue Matrix
Marknadspriser	30 år	Aktiekurser Utdelningar, splittar och åtgärder	ICE Marknadsdata SEC Form S-1
Ägarskap	10 år	Största aktieägare Insiderhandel	SEC Formulär 4 SEC Formulär 13D
Förvaltning	10 år	Ledningsgrupp Styrelse och verkställande direktörer	SEC Form 10-K SEC Form DEF 14A
Viktiga utvecklingstendenser	10 år	Företagsmeddelanden	SEC Formulär 8-K

^* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om den analysmodell som används för att generera denna rapport finns på vår Github-sida, vi har också guider om hur man använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Hextar Healthcare Berhad bevakas av 1 analytiker. 0 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

Analytiker	Institution
Seong Chun Lim	RHB Investment Bank

Hextar Healthcare Berhad Förvaltning

Förvaltning kriterier kontrolleras 1/4

Viktig information

Senaste uppdateringar av ledningen

Hextar Healthcare Berhad Announces Change of Company Secretary

Hextar Healthcare Berhad, Annual General Meeting, May 27, 2024

Hextar Healthcare Berhad Announces the Resignation of Lim Chee Lip, as Executive Director

Hextar Healthcare Berhad Appoints Mastura Binti Muhamad as Company Secretary

Hextar Healthcare Berhad Announces Appointment of Sim Yee Fuan as Independent and Non Executive Member of Nomination and Remuneration Committee

High number of new and inexperienced directors

Recent updates

Full year 2024 earnings released: RM0.013 loss per share (vs RM0.064 loss in FY 2023)

Third quarter 2024 earnings released: RM0.004 loss per share (vs RM0.01 loss in 3Q 2023)

New minor risk - Share price stability

Unpleasant Surprises Could Be In Store For Hextar Healthcare Berhad's (KLSE:HEXCARE) Shares

Hextar Healthcare Berhad Announces Change of Company Secretary

Second quarter 2024 earnings released: RM0.002 loss per share (vs RM0.006 loss in 2Q 2023)

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: RM0.001 (vs RM0.003 loss in 1Q 2023)

Hextar Healthcare Berhad, Annual General Meeting, May 27, 2024

Full year 2023 earnings released: RM0.066 loss per share (vs RM0.062 loss in FY 2022)

New major risk - Share price stability

Hextar Healthcare Berhad Announces the Resignation of Lim Chee Lip, as Executive Director

Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking

Third quarter 2023 earnings released: RM0.01 loss per share (vs RM0.005 loss in 3Q 2022)

New minor risk - Share price stability

Hextar Healthcare Berhad Appoints Mastura Binti Muhamad as Company Secretary

Second quarter 2023 earnings released: RM0.006 loss per share (vs RM0.002 profit in 2Q 2022)

First quarter 2023 earnings released: RM0.003 loss per share (vs RM0.003 profit in 1Q 2022)

Hextar Healthcare Berhad Announces Appointment of Sim Yee Fuan as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.063 loss per share (vs RM0.22 profit in FY 2021)

High number of new and inexperienced directors

Hextar Healthcare Berhad Appoints Lim Siew Eng as Independent and Non Executive Member of Nomination and Remuneration Committee, Effective from January 1, 2023

Hextar Healthcare Berhad Announces Appointment of Wong Yee Leng as Company Secretary

Third quarter 2022 earnings released: RM0.005 loss per share (vs RM0.03 profit in 3Q 2021)

High number of new directors

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) completed the acquisition of Reszon Diagnostics International Sdn. Bhd. from Revongen Corporation Sdn Bhd and Law Eng Lim.

The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing

Second quarter 2022 earnings released: EPS: RM0.002 (vs RM0.078 in 2Q 2021)

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) agreed to acquire Reszon Diagnostics International Sdn. Bhd. from Revongen Corporation Sdn Bhd and Law Eng Lim for RMB 180 million.

We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger

Full year 2021 earnings: EPS and revenues miss analyst expectations

High number of new directors

Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Rubberex Corporation (M) Berhad Announces Redesignation of Mohamed Bin Hamzah from Member of Nomination Committee to Chairman of Nomination Committee

Third quarter 2021 earnings: EPS and revenues miss analyst expectations

Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?

Independent Non Executive Director Mustapha Bin Mohamed has left the company

High number of new directors

Second quarter 2021 earnings released: EPS RM0.078 (vs RM0.028 in 2Q 2020)

Director Jee Liew has joined 5th company board

First quarter 2021 earnings released: EPS RM0.10 (vs RM0.012 in 1Q 2020)

If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS RM0.16 (vs RM0.015 in FY 2019)

What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?

Investor sentiment improved over the past week

Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS RM0.16 (vs RM0.015 in FY 2019)

New 90-day low: RM1.30

Investor sentiment deteriorated over the past week

Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today

Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive

Investor sentiment improved over the past week

How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?

New 90-day low: RM1.35

If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today

New 90-day low: RM1.54

Market pulls back on stock over the past week

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?

Third quarter 2020 earnings released: EPS RM0.05

Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?

Market pulls back on stock over the past week

Rubberex Corporation (M) Berhadd Announces the Appointment of Chan Choun Sien, Independent and Non Executive as Member of Remuneration Committee

Market bids up stock over the past week

Market pulls back on stock over the past week

New 90-day high: RM7.40

First half earnings released